Press Releases
2009
May 19, 2009
Pervasis Therapeutics Presents Promising Preclinical Data for its Minimally Invasive Cell Therapy at the European Association of Percutaneous Cardiovascular Interventions Annual Congress (EuroPCR) [ PDF ]
May 12, 2009
Pervasis Therapeutics to Present Preclinical Data on Novel, Minimally Invasive Cellular Therapy at the European Association of Percutaneous Cardiovascular Interventions Annual Congress [ PDF ]
May 5, 2009
Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel® [ PDF ]
[ back to top ]
2008
November 19, 2008
Pervasis Therapeutics Announces Promising Efficacy Results from Phase 1 and 2 Clinical Trials of Vascugel® in Dialysis Patients Needing Permanent AV Access, Data Builds on Compelling Safety Findings [ PDF ]
November 12, 2008
Pervasis Therapeutics to Present Safety and Efficacy Data from Phase 1 and 2 Clinical Trials of Vascugel® at the 35th Annual VEITHsymposium™ [ PDF ]
November 6, 2008
Pervasis Therapeutics Presents Safety Data from Phase 1 and 2 Clinical Trials of Vascugel® at the American Society of Nephrology Annual Meeting [ PDF ]
October 30, 2008
Pervasis Therapeutics to Present Data from Phase 1 and 2 Clinical Trials of Vascugel® at the American Society of Nephrology 41st Annual Meeting and Scientific Exposition [ PDF ]
October 21, 2008
Pervasis Therapeutics Appoints Life Sciences Industry Executive Frederic Chereau as Company's President and Chief Executive Officer [ PDF ]
October 17, 2008
Pervasis Therapeutics to Present at First Annual Boston Biotech R&D Conference [ PDF ]
August 5, 2008
Pervasis Therapeutics Appoints Frank Litvack, M.D., Former CEO of Conor Medsystems, to its Board of Directors [ PDF ]
January 15, 2008
Pervasis Therapeutics Closes Additional $9.75 Million in Financing [ PDF ]
[ back to top ]
2007
September 17, 2007
Pervasis Therapeutics announces New Animal Study Results Supporting
Vascugel™ in Promoting Healing after Blood Vessel Injury [ PDF ]
August 13, 2007
Pervasis Therapeutics
Successfully Completes Enrollment for Vascugel™ Phase II Clinical
Trials
[ PDF ]
May 15, 2007
Pervasis Therapeutics, Inc. Named to Red Herring 100, Spring 2007 [ PDF ]
April 17, 2007
Pervasis Therapeutics Selected as a Finalist for the Red Herring 100 North
American 2007 [ PDF ]
March 19, 2007
Pervasis
Therapeutics Launches Enrollment for Two Phase II Clinical Trials
for Vascugel [ PDF ]
[ back to top ]
2006
November 15, 2006
Pervasis Therapeutics Announces Successful Initial Safety Results
of Phase I Trials [ PDF ]
September 27, 2006
Pervasis Therapeutics' Vascugel Initiates U.S. Clinical Trials [ PDF ]
[ back to top ]
2005
September 30, 2005
Pervasis Therapeutics Closes 12 Million Series B Financing [ PDF ]
September 30, 2005
Pervasis Therapeutics Expands Team [ PDF ]
[ back to top ]
|
